Australia
Doclink is an Australian healthcare startup founded in 2017 that aims to revolutionize the process of pathology screening and diagnosis. The company utilizes AI and machine learning algorithms to provide rapid, probabilistic diagnoses from medical imaging, with the goal of aiding clinicians and radiologists in providing potentially life-saving early diagnoses for patients.
The startup recently secured a Pre Seed Round investment on 30 October 2018, with Cicada Innovations participating as the investor. This investment reflects the confidence of industry players in Doclink's innovative approach to leveraging technology for early and accurate pathology diagnosis.
Doclink's focus on leveraging advanced technology to address critical healthcare challenges positions it as a promising player in the Health Care industry. The company's innovative use of AI and machine learning has the potential to significantly impact the healthcare sector by enhancing diagnostic accuracy and expediting critical medical interventions. With this recent investment, Doclink is poised to further develop and scale its solutions, potentially making a substantial impact on the global healthcare landscape.
